Primary Job Title Co-Founder, CSO Primary Organization 
Rodin Therapeutics
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Marty is chief scientific officer and co-founder of Rodin Therapeutics and Ataxion. Prior to joining Atlas Venture, Marty spent 27 years at Pfizer, most recently serving as head of neuroscience research. More than 30 development candidates were discovered during his tenure, including veranicline (Chantix), a widely used product for the treatment of
nicotine addiction.
